General Updates

Registered & Corporate Office: AMANTA HEALTHCARE LIMITED 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA. Tel.: 079 – 67777600 Email: info@amanta.co.in Website: www.amanta.co.in CIN: L24139GJ1994PLC023944 Date: September 02, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. Scrip Code: 544502 Trading Symbol: AMANTA Dear Sir / Madam, Subject: - Amanta Healthcare Limited Announces Commissioning of New SteriPort Line Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, as amended from time to time, we would like to inform your good office that Amanta Healthcare Limited, a niche pharmaceutical company specialising in sterile liquids and integrated LVP and SVP manufacturing is happy to announce commencement of production at its new SteriPort facility situated at Kheda campus. SteriPort has unique features like absolute sterility, superior transparency and far more tensile strength. This enhances the container integrity by manifold. It’s two-port system ensures leak- proof IV administration and medication. SteriPort also demonstrates superior compatibility with potent drugs especially in Onco and Intensive Care. The new facility incorporates technological advancements and higher degree of automation primarily aimed at reduced human interference, enhanced quality assurance and patient safety. The brownfield facility is expected to scale up the operational and financial efficiency, resulting into EBITDA margin expansion. This is for your information and records. Thanking you, Yours Faithfully, FOR, AMANTA HEALTHCARE LIMITED NIKHITA DINODIA COMPANY SECRETARY & COMPLIANCE OFFICER Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720